The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial
NCT01948596 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2016-04-21
Summary
The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.
Conditions
- Pregnancy
- Depression
Interventions
- DIETARY_SUPPLEMENT
-
Omega-3 polyunsaturated fatty acids
Sponsors & Collaborators
-
China Medical University, Taiwan
collaborator OTHER -
Japan Society for the Promotion of Science (JSPS)
collaborator UNKNOWN -
University of Toyama
collaborator OTHER -
Chiba University
collaborator OTHER -
Tokyo Medical University
lead OTHER
Principal Investigators
-
Daisuke Nishi, M.D., Ph.D. · Tokyo Medical University
-
Kuan-Pin Su, M.D., Ph.D. · China Medical Univeristy
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-05-31
Countries
- Japan
- Taiwan
Study Locations
More Related Trials
-
Use of Omega-3 Fatty Acids for Perinatal Depression
NCT00402389 ·Status: COMPLETED ·Phase: PHASE2
-
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD
NCT03101540 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health
NCT01353807 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolar Disorder
NCT01371383 ·Status: COMPLETED ·Phase: NA
-
A Study of Omega-3 as a Treatment for Major Depression
NCT00238758 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 for Peri- and Postmenopausal Depression
NCT00825994 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Fatty Acid Trial
NCT00586222 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression
NCT00289484 ·Status: UNKNOWN ·Phase: PHASE2
-
Omega-3 Supplementation and Depression Clinical Trial
NCT01614249 ·Status: COMPLETED ·Phase: NA
-
The Role Of Omega-3 Fatty Acids In Adolescent Depression
NCT00962598 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases
NCT03072823 ·Status: COMPLETED ·Phase: NA
-
A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder
NCT04210804 ·Status: COMPLETED ·Phase: PHASE2
-
N-3 Polyunsaturated Fatty Acids in the Prevention and Treatment for IFN-induced Depression
NCT01620502 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Phospholipids on Perceptual-cognitive Training
NCT01856829 ·Status: COMPLETED ·Phase: NA
-
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303 ·Status: COMPLETED ·Phase: NA
-
The Effect of Fish Oil in Major Depressive Disorder
NCT00816322 ·Status: COMPLETED ·Phase: NA
-
N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes
NCT03871088 ·Status: COMPLETED ·Phase: NA
-
Does Fish Oil Prevent Depression in Pregnancy and Postpartum?
NCT00711971 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies
NCT04069195 ·Status: UNKNOWN ·Phase: NA
-
The Omega-3 Fatty Acid Paediatric Depression Trial
NCT03167307 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity
NCT03297801 ·Status: COMPLETED
-
Omega-3 Fatty Acids for Treating Adults With Major Depression
NCT00517036 ·Status: COMPLETED ·Phase: PHASE3
-
Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
NCT00480207 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
NCT04417595 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2